[Epidemiology and risk factors of adverse outcome in nonvariceal upper gastrointestinal bleeding].

Autor: Tarasov EE; City Clinical Hospital #40, Yekaterinburg, Russian Federation., Bagin VA; City Clinical Hospital #40, Yekaterinburg, Russian Federation., Nishnevich EV; City Clinical Hospital #40, Yekaterinburg, Russian Federation; Ural state medical university, Ministry of health of the Russian Federation, Yekaterinburg, Russian Federation., Astafyeva MN; City Clinical Hospital #40, Yekaterinburg, Russian Federation., Rudnov VA; City Clinical Hospital #40, Yekaterinburg, Russian Federation; Ural state medical university, Ministry of health of the Russian Federation, Yekaterinburg, Russian Federation., Prudkov MI; Ural state medical university, Ministry of health of the Russian Federation, Yekaterinburg, Russian Federation.
Jazyk: ruština
Zdroj: Khirurgiia [Khirurgiia (Mosk)] 2019 (5), pp. 31-37.
DOI: 10.17116/hirurgia201905131
Abstrakt: Aim: To identify risk factors of adverse outcomes in patients with nonvariceal upper gastrointestinal bleeding.
Material and Methods: Epidemiological observational analytical longitudinal retrospective cohort study included 312 patients who were hospitalized in the Clinical Hospital #40 of Yekaterinburg in 2014-2016. The main inclusion criterion was nonvariceal upper gastrointestinal bleeding.
Results: In-hospital mortality was 31 (9.9%) of 312 patients. Multivariate analysis confirmed the following risk factors of mortality: severity of blood loss (OR 22.70, 95% CI 5.08-102.00); open surgery (OR 15.20, 95% CI 2.71-74.80); M. Charlson comorbidity index (OR 2.15, 95% CI 1.34-3.43); risk of recurrent bleeding according to T. Rockall scale (OR 1.76, 95% CI 1.18-2.64).
Conclusion: Independent risk factors of adverse outcomes in patients with nonvariceal upper gastrointestinal bleeding are severe hemorrhagic shock, open surgery, high M. Charlson comorbidity index and risk of recurrent bleeding according to T. Rockall scale.
Databáze: MEDLINE